# Peptide vs protein: what is the difference? Peptides compared with proteins, hormones, collagen and approved medicines

Updated 2026-11-22.

A peptide is a short chain of amino acids. A protein is a longer one. Peptide databases draw the line at fewer than 50 amino acids. Therapeutic peptides usually weigh 500 to 5,000 daltons. No single cut-off is universal. Structure defines a peptide, and job defines a hormone. So a peptide can be a hormone, but a hormone need not be a peptide.

| | |
| --- | --- |
| Peptide length in databases | Fewer than 50 amino acids (Hamdani et al., 2026) |
| Therapeutic peptide mass | Usually 500–5,000 daltons (Wang et al., 2022) |
| Steroid hormones | Built from cholesterol (Miller and Auchus, 2011) |
| C-peptide | 31 amino acids, made in equal amounts with insulin (Leighton et al., 2017) |
| WADA 2026 classes | S1 anabolic agents; S2 peptide hormones, growth factors and mimetics; BPC-157 named in S0 ([WADA 2026 Prohibited List](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf)) |
| Head-to-head obesity trial | SURMOUNT-5: 751 adults, 72 weeks (Aronne et al., 2025) |
| Marine vs bovine collagen, head-to-head human trial | None identified in the 2025 review checked for this page (Bartoletti et al., 2025) |
| Sources checked | 14 October 2026 |

Two words share one border, and there is no sign on it. A search for peptide vs protein is really a search for where one stops and the other starts. The same blurred line runs through hormones, collagen powders, skin serums and the muscle claims that circulate online.

This page is part of [the peptide science hub](/learn/peptide-science). It sets peptides beside proteins, hormones, steroids, collagen and approved medicines. Some questions ask which peptide is strongest or newest for a goal. The answer here is what trials and regulators recorded. No ranking is offered. Research material is not a medicine and is not a substitute for one.

## What is the difference between a peptide and a protein, and between a peptide and a polypeptide?

A peptide and a protein are both chains of amino acids joined by peptide bonds. The difference is length and, in practice, convention. Peptide structure databases call a chain with fewer than 50 amino acids a peptide. A 2026 study argues that this length rule mixes very different cases. In drug development, peptides generally weigh between 500 and 5,000 daltons. That size sits between small-molecule drugs and large proteins. The MeSH vocabulary lists polypeptide as an entry term under Peptides. It treats the two words as one idea ([MeSH record for Peptides](https://meshb.nlm.nih.gov/record/ui?ui=D010455)).

Function often differs along the same line. Collagens are the most abundant large proteins. Their role is mainly structural. Peptides often act as signals. Natural peptide hormones include insulin, oxytocin, vasopressin and GnRH. GnRH is short for gonadotropin-releasing hormone. The table below sets the two beside a steroid hormone.

Digestion links the two. Dietary protein is broken into short peptides. The intestine absorbs di- and tripeptides through the PEPT1 transporter. [The peptide bond page](/learn/peptide-science/what-is-a-peptide-bond) explains the link that joins every chain.

Is protein better than peptides? The question compares things that are not rivals. A protein is a long chain and a peptide is a short one. Either can be food, a hormone or a medicine. None of the sources checked compares them head to head.

## How does a peptide differ from a hormone?

A peptide is defined by structure. It is a chain of amino acids. A hormone is defined by role. It is a chemical signal released in one place to act in another. The two sets overlap. Insulin, oxytocin, vasopressin and GnRH are peptide hormones. Steroid hormones such as testosterone are hormones that are not peptides. The body builds them from cholesterol. Many peptides are not hormones at all. Two examples are antimicrobial peptides and [cell-penetrating peptides](/learn/peptide-science/cell-penetrating-peptides).

Sport's anti-doping list follows the same split. The [WADA 2026 list](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf) puts anabolic agents, including steroids, in class S1. It puts peptide hormones, growth factors, related substances and mimetics in class S2. WADA bans both classes at all times. The list is in force from 1 January 2026. [The page on what peptides are](/learn/peptide-science/what-are-peptides) answers the related question of whether peptides are steroids.

## What is the difference between synthetic and natural peptides?

A natural peptide is made by a living thing. A synthetic peptide is made in a lab or factory. The molecule can be identical. Both chemical and biological methods can make and change peptides. Chemical synthesis builds the chain on a solid support, one amino acid at a time. Fmoc synthesis is now the usual method. Origin does not decide safety or legal status. The TGA treats unapproved peptide products as untested for safety, quality and effectiveness. This holds whatever their origin ([TGA, 23 September 2026](https://www.tga.gov.au/resources/explore-topic/peptide-products)).

Developers also change peptides on purpose. Liraglutide, semaglutide and insulin degludec are approved peptide drugs. They carry fatty acids. Wang and colleagues report that such changes make the drug stay longer in the blood.

## What are the differences between research peptides and compounded peptides?

Research peptides are lab materials labelled for research use only. Compounded peptides are made by a pharmacist or practitioner for one patient. The TGA says a research use only label does not change how a product is regulated. A not for human use label does not change it either ([TGA guidance](https://www.tga.gov.au/products/medicines/monitoring-and-compliance/how-we-regulate-therapeutic-peptide-products)). Compounded goods are usually exempt from the register of therapeutic goods in two cases. One is when they are made for one person. The other is when a hospital pharmacist makes them for the hospital's patients ([TGA advisory, 13 April 2026](https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/understanding-your-responsibilities-when-importing-compounding-and-supplying-unapproved-peptide-products)).

Neither label makes a product approved. The TGA's April 2026 advisory names BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 as unapproved peptide products. Its page for practitioners adds that compounded peptide products may be therapeutic goods. Then rules apply. They cover making, supplying, prescribing and advertising ([TGA advisory, 13 April 2026](https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/understanding-your-responsibilities-when-importing-compounding-and-supplying-unapproved-peptide-products); [TGA page for practitioners](https://www.tga.gov.au/resources/explore-topic/peptide-products/peptide-product-information-health-practitioners)). [The law hub](/learn/peptides-and-australian-law) records schedule status by compound.

## How do collagen peptides compare with marine and bovine collagen?

Collagen peptides are hydrolysed collagen. That means collagen broken into small pieces. Marine collagen comes from fish and other water animals. Bovine collagen comes from cattle. The most common industrial sources are bovine and pig. Marine collagen is an emerging alternative. Marine collagens are mostly type I. The 2025 review checked for this page found no head-to-head human trial of marine against bovine hydrolysate. It says high-level human studies are scarce for both. It says no head-to-head comparisons exist. A claim that one is better lacks direct trial support in that review.

Allergy is one documented difference. A 2000 lab analysis tested serum samples from three small patient groups (10, 2 and 15 patients). IgE antibodies showed little cross-reactivity between fish and bovine gelatins. The study tested gelatin, not collagen supplements. The 2025 marine collagen review also says marine collagen avoids the risk of passing on prion disease from animals. Mad cow disease is one example. That is the review's statement from the literature. It is not a trial result.

On skin, a 2021 meta-analysis pooled 19 randomised, double-blind, controlled trials with 1,125 participants. The results favoured hydrolysed collagen over placebo. This covered skin hydration, elasticity and wrinkles. A published comment raised a concern. The studies differed too much. That limits how far you can read the pooled result.

## What have studies found about peptides in skin care, and are multi-peptide serums good for skin?

In the sources checked, controlled studies of skin-care peptides are few and short. One was a 12-week split-face trial of 93 women aged 35 to 55. A moisturiser with the peptide pal-KTTKS gave a significant improvement in wrinkles and fine lines. The comparison was a control moisturiser. It was one trial of one formula in one age band. It does not show results for other peptides. None of the sources tested a multi-peptide serum, which is a mix of several peptides. So no study result is available for that product type. None ranked one peptide moisturiser against another.

Oral and topical routes are different experiments. The collagen meta-analysis studied collagen supplements that people swallow. The topical trial studied a face cream. Neither compared the two. So these sources give no head-to-head answer on whether peptide or collagen is better for skin.

On mature skin, none of the sources opened analysed results by age beyond the 35 to 55 range of the pal-KTTKS trial.

## Which peptide medicines show the largest weight or blood-sugar changes in published trials?

Published trials report different weight changes for different approved medicines. You cannot rank results from different trials against each other. One head-to-head trial in obesity is SURMOUNT-5. It split 751 adults with obesity, but without type 2 diabetes, between tirzepatide and semaglutide for 72 weeks. Weight fell by 20.2% and 13.7%. The maker of tirzepatide paid for this open-label trial. It applies to those two medicines and that group of people.

Placebo-controlled trials give separate figures. STEP 1 ran for 68 weeks in 1,961 adults without diabetes. Mean body weight fell by 14.9% with semaglutide. It fell by 2.4% with placebo. The maker of semaglutide paid for it. It applies to that medicine and population. SURMOUNT-1 ran for 72 weeks in 2,539 adults without diabetes. Weight fell by 15.0%, 19.5% and 20.9% in the three tirzepatide groups. It fell by 3.1% with placebo. The maker of tirzepatide backed it. So it describes that medicine in that population only. SURPASS-2 ran for 40 weeks in 1,879 adults with type 2 diabetes. Glycated haemoglobin fell by 2.01, 2.24 and 2.30 percentage points in the three tirzepatide groups. It fell by 1.86 with semaglutide. This head-to-head result is limited to those two medicines and that trial population.

Newest depends on the date of the trial. The most recent of these came out in 2025. Retatrutide is an investigational peptide. It was in human trials. As of the TGA's 14 September 2026 advisory, no regulator had approved it ([TGA advisory, 14 September 2026](https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/tga-tests-counterfeit-retatrutide-product-following-serious-adverse-event-report)). [How retatrutide compares with Mounjaro and Ozempic](/learn/retatrutide/retatrutide-vs-mounjaro-vs-ozempic) reads that record. Research material is not a substitute for an approved medicine. These results are for medicines studied under trial and regulatory conditions only.

## What have studies found about peptides and joint, tendon or muscle injury?

The evidence is mostly from animals. A 2025 review of BPC-157 in sports bone and joint medicine included 36 studies. Thirty-five of them were done before human trials. It found better function, structure and strength in animal models of muscle, tendon, ligament and bone injury. This does not show the same effects in humans. The one clinical study was a small report looking back at chronic knee pain of unknown cause. In it, 7 of 12 patients reported relief lasting more than six months. That design cannot show cause. The same review found no clinical safety data.

The review's study table lists a 1997 rat model of induced inflammatory arthritis. The review text mentions no human arthritis study. It mentions no study of meniscus tears and none of back pain. Its authors describe the evidence as level IV and level V studies. They warn that harm is possible because of unregulated making, contamination or unknown clinical safety. The review records that BPC-157 lacks FDA approval and is banned in professional sports. WADA's 2026 list names it in class S0 ([WADA 2026 Prohibited List](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf)). [The BPC-157 Perth guide](/learn/peptides-perth/bpc-157-perth) covers supply and legal context.

## Do peptides build muscle, and what does the anti-doping code say?

The sources checked include no controlled human trial showing that peptides sold for muscle gain build muscle. The TGA says many peptide products sold for weight loss, muscle growth, anti-ageing, recovery and performance are unapproved. Nobody has tested them for safety, quality or effectiveness. Sport has a clear rule. WADA bans these groups at all times: growth hormone fragments such as AOD-9604, growth hormone-releasing factors such as CJC-1295 and tesamorelin, secretagogues such as ipamorelin, and thymosin-beta-4 derivatives such as TB-500. They sit in class S2 of the [WADA 2026 list](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf).

Words such as jacked, ripped and shredded describe appearance goals. The trials above did not measure them. The sources checked record no trial that measured them for peptides. Creatine is a common comparison, but it is not a peptide. Its PubChem record gives C4H9N3O2 and a molecular weight of 131.13. It is a single small molecule, not a chain of amino acids ([PubChem record for creatine](https://pubchem.ncbi.nlm.nih.gov/compound/586)). A peptide-versus-creatine contest compares different kinds of substance. None of the sources compares them.

## Which peptides are linked to testosterone?

Testosterone is a steroid hormone, not a peptide. But peptides sit upstream of it. The [WADA 2026 list](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf) names some peptides that stimulate testosterone in males, at S2.2.1. These are chorionic gonadotrophin, luteinizing hormone, GnRH and its agonist analogues, and kisspeptin. WADA bans them at all times. Testosterone itself has the formula C19H28O2. It has no amino-acid chain ([PubChem record for testosterone](https://pubchem.ncbi.nlm.nih.gov/compound/6013)). The body builds steroid hormones from cholesterol. So the question has two parts. One is peptides that act on the hormone system. The other is the hormone itself.

Approved medicines work in this area from the other direction. Degarelix blocks the GnRH receptor. It was first approved in 2008 for advanced prostate cancer. No source checked describes a peptide for raising a healthy man's testosterone. The TGA says nobody has tested unapproved peptide products sold online.

## How is C-peptide different from insulin and from A1c, and what is it used for?

C-peptide and A1c measure different things. C-peptide reflects the body's own insulin output. Beta cells release it in equal amounts with insulin. A1c is the glycated haemoglobin test. It tracks average blood glucose, because HbA1c has a close mathematical link to mean glycaemia. So A1c is not the same test as C-peptide. C-peptide is also called the proinsulin connecting peptide.

Today, C-peptide mainly helps sort and manage patients who use insulin. It is most useful 3 to 5 years after diagnosis. At that point, a lot of insulin output suggests type 2 or monogenic diabetes. Absent C-peptide at any time confirms the person must have insulin. It also supports the diagnosis of insulinoma. It helps check low blood sugar not caused by diabetes.

The sources checked give no single answer on which peptide treats diabetes best. Approved GLP-1 medicines, pramlintide and insulin each have approved uses. The trial figures above show how two of them compare in one head-to-head trial.

## How long do peptides stay in the body?

Peptides leave the body at very different speeds. Studies report a half-life. This is the time for the blood level to fall by half. A review of C-peptide testing gives insulin a half-life of 3 to 5 minutes. It gives C-peptide 20 to 30 minutes. A 1995 study looked at eight people with type 2 diabetes. Thirty minutes after native GLP-1 exposure, a breakdown product made up 88.5% of the rise in blood GLP-1 immunoreactivity. That was a small study of the natural hormone. It was not a study of any research peptide. The US label for semaglutide records a half-life of about one week. That figure is for the approved medicine, not for research material ([DailyMed Ozempic label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)).

A half-life is not a clearance time. Total clearance takes longer than one half-life. No source checked gives a total clearance time for the research peptides discussed online. Retatrutide is an investigational medicine. A phase 1 study in people reported figures on how the body handles it. That was an early study. It does not apply to research material. [Retatrutide pharmacokinetics](/learn/retatrutide/retatrutide-pharmacokinetics) sets out the published figures.

## Is there a peptide for ADHD or for the brain?

No peptide is listed for ADHD in the table of peptide drugs approved since 2000 in Wang et al. (2022). Two approved peptides in that table act on the nervous system. Taltirelin was first approved in 2000 for spinocerebellar degeneration. Ziconotide was first approved in 2004 for severe chronic pain. Regulators have not looked at research compounds sold for thinking skills. The TGA says nobody has checked the online claims for unapproved peptide products. Those claims include mental and sports performance (TGA advisory, 13 April 2026).

ADHD treatment is a clinical question outside what these sources address. For brain research, the sources checked contain animal work only. In 2021, Sun and colleagues tested Dihexa, a modified peptide, in a mouse model of Alzheimer's disease. The abstract gives no mouse count. An animal study does not establish an effect in humans. [The peptide bond page](/learn/peptide-science/what-is-a-peptide-bond) describes it.

## Comparison

Definitions as used in the source named in each cell. The rules differ. None is a universal rule or a legal definition.

| Feature | Peptide | Protein | Steroid hormone |
| --- | --- | --- | --- |
| Building units | Amino acids joined by peptide bonds (TGA, 23 September 2026) | Amino acids joined by peptide bonds in longer chains; peptides are their building blocks | Built from cholesterol, not from amino acids (Miller and Auchus, 2011) |
| Size convention | Fewer than 50 amino acids in databases; therapeutic peptides usually 500 to 5,000 daltons | Longer chains; no single universal cut-off (Hamdani et al., 2026) | Not a chain; testosterone is C19H28O2 ([PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/6013)) |
| Example | C-peptide, 31 amino acids (Leighton et al., 2017) | Collagen, a structural protein (Silva et al., 2014) | Testosterone |
| Typical role named in the sources | Signals, hormones and medicines, such as insulin (Wang et al., 2022) | Often structural, as collagens are (Silva et al., 2014) | Hormones, listed with anabolic agents in WADA class S1 ([WADA 2026 Prohibited List](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf)) |

## Frequently asked questions

### Can you get in trouble for peptides?

It depends on the activity. The TGA says unapproved peptide products cannot be imported or supplied unless an exemption, approval or authority applies. Civil penalties under the Therapeutic Goods Act go up to $1.82 million per breach for individuals. Criminal penalties go up to 7 years in prison ([TGA advisory, 14 September 2026](https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/tga-tests-counterfeit-retatrutide-product-following-serious-adverse-event-report)). The [Personal Importation Scheme](https://www.tga.gov.au/products/unapproved-therapeutic-goods/access-pathways/personal-importation-scheme) allows personal import only when every condition is met. The TGA page was updated on 8 September 2026. This sums up regulator pages. It is not legal advice. [The law hub](/learn/peptides-and-australian-law) has more.

### Is a peptide better than creatine?

The sources checked do not compare them. They are different kinds of substance. A peptide is a chain of amino acids. Creatine is a single small molecule that is not a peptide ([PubChem record for creatine](https://pubchem.ncbi.nlm.nih.gov/compound/586)).

### Is there a peptide for hair growth?

The one study found was a laboratory study. In a 2007 study, the abstract gives no sample count. The copper tripeptide AHK-Cu lengthened human hair follicles kept in culture. It also increased the growth of dermal papilla cells. The authors proposed that it acts by promoting cell growth and limiting programmed cell death. The fall in dying cells was not statistically significant. So the study does not establish an effect on a person's scalp. No human trial of a peptide for hair growth was found in the sources checked.

### What is another name for C-peptide?

Connecting peptide. Shao and colleagues call it the human proinsulin connecting peptide. It has 31 amino acids. Beta cells make it with insulin in equal amounts.

## Citations

- Hamdani R et al.. Protein Science. 2026;35(10):e70779. DOI: 10.1002/pro.70779
- Wang L et al.. Signal Transduction and Targeted Therapy. 2022;7:48. DOI: 10.1038/s41392-022-00904-4
- Silva T et al.. Marine Drugs. 2014;12:5881-5901. DOI: 10.3390/md12125881
- Daniel H.. Annual Review of Physiology. 2004;66:361-384. DOI: 10.1146/annurev.physiol.66.032102.144149
- Miller WL, Auchus RJ.. Endocrine Reviews. 2011;32:81-151. DOI: 10.1210/er.2010-0013
- Mookherjee N et al.. Nature Reviews Drug Discovery. 2020;19:311-332. DOI: 10.1038/s41573-019-0058-8
- Milletti F.. Drug Discovery Today. 2012;17:850-860. DOI: 10.1016/j.drudis.2012.03.002
- Behrendt R et al.. Journal of Peptide Science. 2016;22:4-27. DOI: 10.1002/psc.2836
- Bartoletti E et al.. Clinical, Cosmetic and Investigational Dermatology. 2025;18:3339-3356. DOI: 10.2147/CCID.S562518
- Sakaguchi M et al.. Journal of Allergy and Clinical Immunology. 2000;106:579-584. DOI: 10.1067/mai.2000.108499
- de Miranda RB et al.. International Journal of Dermatology. 2021;60:1449-1461. DOI: 10.1111/ijd.15518
- Peres G et al.. International Journal of Dermatology. 2022;61(3), comment on de Miranda et al., 2021. DOI: 10.1111/ijd.15748
- Robinson LR et al.. International Journal of Cosmetic Science. 2005;27:155-160. DOI: 10.1111/j.1467-2494.2005.00261.x
- Aronne LJ et al.. New England Journal of Medicine. 2025;393:26-36. DOI: 10.1056/NEJMoa2416394
- Wilding JPH et al.. New England Journal of Medicine. 2021;384:989-1002. DOI: 10.1056/NEJMoa2032183
- Jastreboff AM et al.. New England Journal of Medicine. 2022;387:205-216. DOI: 10.1056/NEJMoa2206038
- Frías JP et al.. New England Journal of Medicine. 2021;385:503-515. DOI: 10.1056/NEJMoa2107519
- Vasireddi N et al.. HSS Journal. 2025;21:485-495. DOI: 10.1177/15563316251355551
- Leighton E et al.. Diabetes Therapy. 2017;8:475-487. DOI: 10.1007/s13300-017-0265-4
- Jones AG, Hattersley AT.. Diabetic Medicine. 2013;30:803-817. DOI: 10.1111/dme.12159
- Shao R et al.. International Journal of Molecular Sciences. 2026;27(1):483. DOI: 10.3390/ijms27010483
- Sacks DB et al.. Diabetes Care. 2011;34:e61-e99. DOI: 10.2337/dc11-9998
- Deacon CF et al.. Diabetes. 1995;44:1126-1131. DOI: 10.2337/diab.44.9.1126
- Coskun T et al.. Cell Metabolism. 2022;34:1234-1247.e9. DOI: 10.1016/j.cmet.2022.07.013
- Sun X et al.. Brain Sciences. 2021;11:1487. DOI: 10.3390/brainsci11111487
- Pyo HK et al.. Archives of Pharmacal Research. 2007;30:834-839. DOI: 10.1007/BF02978833

[Research peptide reference material catalogue](/shop)

Research use only, not for human or animal use.

[Read the peptide science hub](/learn/peptide-science)

---

Canonical page: https://www.formlaboratories.com/learn/peptide-science/peptide-vs-protein

Form Laboratories - Perth-based research-use-only peptide supplier, shipping Australia-wide.

- Site guide for agents: https://www.formlaboratories.com/llms.txt
- Sitemap: https://www.formlaboratories.com/sitemap.xml
- Full catalogue: https://www.formlaboratories.com/shop
- Contact: hello@formlaboratories.com

All materials are supplied for laboratory research use only - not for human or veterinary use, and nothing on this site is medical advice.